---
title: "Enerpac Tool Group Reports Q3 Fiscal 2026: Revenue $167.6M, Net Income $29.8M, Adjusted EPS $0.60"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292069370.md"
description: "Enerpac Tool Group reported Q3 fiscal 2026 net sales of $167.6M, up 6% year-over-year, with net income of $29.8M and adjusted EPS of $0.60. The company announced a definitive agreement to acquire SFE Group and repurchased approximately $15 million in stock. Gross margin expanded to 53.0%, driven by tariff refunds and organic growth, particularly from Cortland Biomedical."
datetime: "2026-07-08T12:33:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292069370.md)
  - [en](https://longbridge.com/en/news/292069370.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292069370.md)
---

# Enerpac Tool Group Reports Q3 Fiscal 2026: Revenue $167.6M, Net Income $29.8M, Adjusted EPS $0.60

Enerpac Tool Group reported third-quarter fiscal 2026 results with net sales of $167.6 million, a 6% year-over-year increase and $29.8 million in net earnings ($0.58 diluted EPS). Adjusted diluted EPS was $0.60 for the quarter and adjusted EBITDA reached $46.9 million, reflecting margin expansion. The company also announced a definitive agreement to acquire SFE Group and repurchased roughly $15 million of stock in the quarter.

**Financial Highlights**

-   Revenue: Net sales of $167.6 million for the three months ended May 31, 2026 (6% increase vs. prior year; 3% organic growth).
-   Gross profit and margin: Gross profit of $88.8 million; gross margin of 53.0% (up 260 basis points year over year, including expected IEEPA tariff refund benefit).
-   Operating income: Operating profit of $41.4 million for the quarter.
-   Net income and EPS: Net earnings of $29.8 million; diluted EPS of $0.58 for the quarter.
-   Adjusted results: Adjusted diluted EPS of $0.60 and adjusted EBITDA of $46.9 million (adjusted EBITDA margin 28.0%).

**Business Highlights**

-   Segment performance: Industrial Tool & Service (IT&S) product sales increased 5% organically year over year while IT&S service revenue declined 8% organically; service revenue improved 17% sequentially.
-   Growth drivers: Cortland Biomedical delivered 25% year-over-year growth in the quarter, contributing to consolidated organic sales growth.
-   Capital allocation: Returned approximately $15 million to shareholders via repurchases (about 420,000 shares); $120 million remains available under the $200 million authorization.
-   Acquisition activity: Signed a definitive agreement to acquire Specialized Fabrication Equipment (SFE) Group to expand complementary product offerings and reach in higher-growth markets and geographies.
-   Cash generation and liquidity: Year-to-date cash provided by operations of $69.3 million; cash balance of $115.7 million and net debt to adjusted EBITDA of 0.5x as of May 31, 2026.

Original SEC Filing: ENERPAC TOOL GROUP CORP \[ EPAC \] - 8-K - Jul. 08, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [EPAC.US](https://longbridge.com/en/quote/EPAC.US.md)

## Related News & Research

- [Enerpac Tool Group director E James Ferland Jr disposes of 2,930 common shares for $100,646.55](https://longbridge.com/en/news/293951821.md)
- [Enerpac Tool Group agrees to buy SFE Group for $472 million cash](https://longbridge.com/en/news/292180576.md)
- [Greif fiscal Q3 revenue beats estimates on higher prices](https://longbridge.com/en/news/294108067.md)
- [Ireland's Johnson Controls Q3 sales beat on data center demand; raises outlook](https://longbridge.com/en/news/294196601.md)
- [Ciena's Q3 2026 Earnings: What to Expect](https://longbridge.com/en/news/293952665.md)